In 1999 Jerry Brunetti was diagnosed with Non-Hodgkin’s Lymphoma and given 6 months to live. He did not submit to chemotherapy, but rather, developed his own unique dietary approach to enhance his immune system. In this informative video, Jerry shares his personal experiences and provides his recipe for healthy living. You will learn about the crucial importance of minerals, which foods to choose for your best health requirements and what to avoid. After viewing this video you’ll realize the remarkable value of food in building good foundations, and providing buffers, to keep your body healthy.
Topics of the first video include:
- Why we are losing the ‘war’ on Cancer
- Metastasis kills 90% of the cancer patients; 50% die of cachexia (wasting disease).
- The virtue of the immune system in combating disease, including cancer.
- Chemotherapy agents MOP and CHOP are derivatives of WWI mustard gas.
- Angiogenesis and why cutting out the primary tumor is bad.
- Obesity, diabetes and the sugar consumption explosion.
- The greatest of health threats called Iatrogenic disease – illness caused by modern medicine.
- The superficiality of regular medicine with regards to the US cancer patient.
- Negative synergy of cocktails of different toxins.
- Why Prunes and Eggs are healthy foods.
- Selenium the antidote to mercury.
- The benefits of resveratrol.
- The benefits of Blueberries, Strawberries, Raspberries, Cranberries, Apples, Elderberries, Black Cherries, Lycopene, Pumpkins.
- How foods barely contain minerals in the US.
- Vegetables of the cross/cruciferous vegetables – “nr 1 vegetables in protecting against cancer”.
- Why antacids are not the answer to your stomach troubles.
Check out the accompanying resources page for slides and food advice.
Video 1; Part 1of10
Video 1; Part 3of10
Video 1; Part 4of10
Video 1; Part 5of10
Video 1; Part 6of10
Video 1; Part 7of10
Video 1; Part 8of10
Video 1; Part 9of10
Video 1; Part 10of10
Video 2; Part 1of9
Video 2; Part 2of9
Video 2; Part 3of9
Video 2; Part 4of9
Video 2; Part 5of9
Video 2; Part 6of9
Video 2; Part 7of9
Video 2; Part 8of9
Video 2; Part 9of9
Judah Folkman pioneered the idea that blocking the growth of blood vessels (right in the framed picture) to a cancer tumor (left) will stop, even reverse its growth. After more than 30 years of controversy, drugs developed in his lab are proving that he is right. (Staff photo Jon Chase/Harvard News Office)
Notes: (blue bold-faced emphasis is all mine)
-
Angiogenesis is a physiological process involving the growth of new blood vessels from pre-existing vessels. Though there has been some debate over this, vasculogenesis is the term used for spontaneous blood-vessel formation, and intussusception is the term for new blood vessel formation by splitting off existing ones.
Angiogenesis is a normal process in growth and development, as well as in wound healing. However, this is also a fundamental step in the transition of tumors from a dormant state to a malignant state.
-
Understanding Cancer Series: Angiogenesis
Cancer researchers studying the conditions necessary for cancer metastasis have discovered that one of the critical events required is the growth of a new network of blood vessels. This process of forming new blood vessels is called angiogenesis.
Tumor angiogenesis is the proliferation of a network of blood vessels that penetrates into cancerous growths, supplying nutrients and oxygen and removing waste products. Tumor angiogenesis actually starts with cancerous tumor cells releasing molecules that send signals to surrounding normal host tissue. This signaling activates certain genes in the host tissue that, in turn, make proteins to encourage growth of new blood vessels.
Before the 1960s, cancer researchers believed that the blood supply reached tumors simply because pre-existing blood vessels dilated. But later experiments showed that angiogenesis--the growth of the new blood vessels--is necessary for cancerous tumors to keep growing and spreading.
In early experiments, researchers asked whether cancer growth requires angiogenesis. Scientists removed a cancerous tumor from a laboratory animal and injected some of the cancer cells into a normal organ removed from the same strain of animal. The organ was then placed in a glass chamber and a nutrient solution was pumped into the organ to keep it alive for a week or two. Scientists found that the cancer cells grew into tiny tumors but failed to link up to the organ's blood vessels. As a result, tumor growth stopped at a diameter of about 1-2mm. Without angiogenesis, tumor growth stopped.
http://www.cancer.gov/cancertopics/UnderstandingCancer/angiogenesis
-
Dr. Moses Judah Folkman (February 24, 1933 – 14 January 2008) was an American medical scientist best known for his research on angiogenesis and vasculogenesis, processes where tumors generate tiny blood vessels to nourish themselves. His work founded a branch of cancer research called ‘anti-angiogenesis therapy‘.
[…]
Work on angiogenesisIn 1971, he published an article in the New England Journal of Medicine, stating that all cancer tumors were angiogenesis-dependent. He postulated that if a tumor could be stopped from growing its own blood supply, it would wither and die. Though his hypothesis was disregarded by most experts in the field at first, Folkman continued his research.
After more than a decade, his theory became widely accepted. He was considered the leading expert and founder of the angiogenesis field, which now offers many potentials in medicine, including reversing blindness caused by macular degeneration[4]. He trained numerous leaders in medicine and biomedical engineering, including Donald Ingber and Robert Langer.
Dr. Folkman pioneered the use of interferon in cancer therapy, healing hemangiomas, growths that often threaten the life of infants. His research has led to the development of progressively more potent compounds, such as angiostatin, endostatin and vasculostatin, which have successfully halted the growth of tumors in laboratory mice[5].
In 2000, a pharmaceutical company sued Dr. Folkman, contending that he and Children’s Hospital in Boston stole the credit for developing a promising drug that cuts off the blood supply to tumors[6][7], and he countersued to defend his reputation[8].
At least 50 angiogenesis inhibitors – including endostatin, angiostatin, 2ME2 (Panzem), and a thrombospondin analog — are in clinical trials today for cancer, including a variety of drugs that have been discovered to have unexpected anti-angiogenic effects. These include the anti-inflammatory drug celecoxib (Celebrex); rosiglitazone (Avandia), a drug commonly used to treat Type 2 diabetes; doxycycline, a common antibiotic; and some cancer drugs that also have other mechanisms of action, including Erbitux, Herceptin, Velcade and Tarceva. Even some conventional chemotherapy drugs have demonstrated anti-angiogenic effects when given in frequent, smaller doses (see Anti-Angiogenic Chemotherapy below). Folkman envisioned that someday angiogenesis inhibitors would be used together or in combination with conventional anticancer therapies such as chemotherapy, radiotherapy, immunotherapy, gene therapy, or vaccine therapy.[9]
-
Sugar’s effect on your health
[…]
In the last 20 years, we have increased sugar consumption in the U.S. 26 pounds to 135 lbs. of sugar per person per year! Prior to the turn of this century (1887-1890), the average consumption was only 5 lbs. per person per year! Cardiovascular disease and cancer was virtually unknown in the early 1900’s.
[…]
One of sugar’s major drawbacks is that it raises the insulin level, which inhibits the release of growth hormones, which in turn depresses the immune system. This is not something you want to take place if you want to avoid disease.An influx of sugar into the bloodstream upsets the body’s blood-sugar balance, triggering the release of insulin, which the body uses to keep blood-sugar at a constant and safe level. Insulin also promotes the storage of fat, so that when you eat sweets high in sugar, you’re making way for rapid weight gain and elevated triglyceride levels, both of which have been linked to cardiovascular disease. Complex carbohydrates tend to be absorbed more slowly, lessening the impact on blood-sugar levels.
Sugar depresses the immune system.
We have known this for decades. It was only in the 1970’s that researchers found out that vitamin C was needed by white blood cells so that they could phagocytize viruses and bacteria. White blood cells require a 50 times higher concentration inside the cell as outside so they have to accumulate vitamin C.
[…]
We know that glucose and vitamin C have similar chemical structures, so what happens when the sugar levels go up? They compete for one another upon entering the cells. And the thing that mediates the entry of glucose into the cells is the same thing that mediates the entry of vitamin C into the cells. If there is more glucose around, there is going to be less vitamin C allowed into the cell. It doesn’t take much: a blood sugar value of 120 reduces the phagocytic index by 75%. So when you eat sugar, think of your immune system slowing down to a crawl.
[…]
Because sugar is devoid of minerals, vitamins, fiber, and has such a deteriorating effect on the endocrine system, major researchers and major health organizations (American Dietetic Association and American Diabetic Association) agree that sugar consumption in America is one of the 3 major causes of degenerative disease.
[…]
Sugar and cancerOf the over 4 million cancer patients being treated in the U.S. today, almost none are offered any scientifically guided nutrition therapy other than being told to “just eat good foods.” Many cancer patients would have a major improvement in their conditions if they controlled the supply of cancer’s preferred fuel: GLUCOSE. By slowing the cancer’s growth, patients make it possible for their immune systems to catch up to the disease. Controlling one’s blood-glucose levels through diet, exercise, supplements, meditation and prescription drugs – when necessary – can be one of the most crucial components to a cancer treatment program. The saying “Sugar feeds cancer” is simple. The explanation is a little more involved.
German Otto Warburg, Ph.D., the 1931 Nobel laureate in medicine, first discovered that cancer cells have a fundamentally different energy metabolism compared to healthy cells. The gist of his Nobel thesis was this: malignant tumors frequently exhibit an increase in “anaerobic glycolysis” – a process whereby glucose is used by cancer cells as a fuel with lactic acid as an anaerobic by-product – compared to normal tissues.(1) The large amount of lactic acid produced by this fermentation of glucose from the cancer cells is then transported to the liver. This conversion of glucose to lactate creates a lower, more acidic PH in cancerous tissues as well as overall physical fatigue from lactic acid build-up.(2,3) Therefore, larger tumors tend to exhibit a more acidic PH.(4) -
Treating Insulin Resistance with Cinnamon
Cinnamon may be a very useful herb for treating the insulin resistance that frequently accompanies polycystic ovarian syndrome (PCOS). Several new studies indicate that this delicious spice can lower blood glucose levels. This is not a new finding, but the recent studies help us to better understand how it works.
A recent press release from the University of California, Santa Barbara stated, “Cinnamon may be more than a spice – it may have a medical application in preventing and combating diabetes. Cinnamon may help by playing the role of an insulin substitute in type II diabetes, according to cellular and molecular studies at the University of California, Santa Barbara, Iowa State University and the U.S. Department of Agriculture.
‘Cinnamon itself has insulin-like activity and also can potentiate the activity of insulin,’ said Don Graves of UCSB. ‘The latter could be quite important in treating those with type II diabetes. Cinnamon has a bio-active component that we believe has the potential to prevent or overcome diabetes.’ Women who suffer from polycystic ovarian syndrome nearly always benefit from treatments for insulin resistance-whether or not they are diagnosed as insulin resistant. Further, the risk of developing diabetes is nearly 40% for women with PCOS-a very good reason to work to improve your insulin response.”
Study dosages ranged from ¼ teaspoon to 1 teaspoon per day for type 2 diabetics, but more research is needed about effective amounts for those with insulin resistance. The active chemical is MHCP or methylhydroxychalcone polymer. This chemical is found in all types of cinnamon sold as a spice in the U.S. In the U.S. Cinnamomum cassia is legally sold as cinnamon. However, true cinnamon is Cinnamomum zeylanicum, or Cinnamomum verum.
MHCP has been shown to lower blood glucose levels, triglycerides and LDL cholesterol. Insuline resistance causes elevated blood glucose, triglycerides and LDL cholesterol. It is also an antioxidant. This is important because women with PCOS are more susceptible to the effects of the breakdown of cells due to oxidation.
-
A Phil-for-an-ill Blog 